newsfilter
← Latest News
GlobeNewswire·

Clene to Participate in a Panel Discussion at the Maxim Growth Summit

SALT LAKE CITY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company